Synaptogenix, Inc., a clinical-stage biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, announced plans to develop Bryostatin-1 for the treatment of multiple sclerosis ("MS"),...
Jacobio Pharmaceuticals announced that its KRAS G12C inhibitor JAB-21822 completed the first patient dosing in combination therapy with Cetuximab at Peking University Cancer Hospital...
Roche announced the expansion of the COVID-19 PCR portfolio to the cobasⓇ 5800 System, a recently launched molecular laboratory instrument, in countries accepting the...
SummerBio LLC, a diagnostic company that provides affordable, high-quality, high-volume COVID-19 PCR testing, announced that it is expanding its COVID-19 PCR testing capabilities and...
